Results 121 to 130 of about 46,924 (216)

HIV gp120; CD4 [PDF]

open access: yesScience-Business eXchange, 2012
openaire   +1 more source

Author Correction: NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology. [PDF]

open access: yesCell Mol Immunol
He X   +19 more
europepmc   +1 more source

HIV gp120; CD4 [PDF]

open access: yesScience-Business eXchange, 2010
openaire   +1 more source

Comprehensive analysis of gp120 glycosylation to explore differences between transmitter/founder and chronic HIV-1 isolates. [PDF]

open access: yesGlycobiology
Temesy S   +11 more
europepmc   +1 more source

Retraction Note: Neuroprotective effects of the Immunomodulatory drug FK506 in a model of HIV1-gp120 neurotoxicity. [PDF]

open access: yesJ Neuroinflammation
Fields JA   +9 more
europepmc   +1 more source

AS01<sub>B</sub>-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a <i>post-hoc</i> cross-protocol comparison of results from HVTN 100, 107, 120, and 702. [PDF]

open access: yesFront Immunol
Menezes F   +15 more
europepmc   +1 more source

Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV. [PDF]

open access: yesJ Infect Dis
Benlarbi M   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy